We are live on ! Find out more
STDY

SteadyMed Ltd
STDY

Delisted

STDY was delisted on the 29th of August, 2018.

Back to rankings

15 hedge funds and large institutions have $33.8M invested in SteadyMed Ltd in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

131% more capital invested

Capital invested by funds: $14.6M → $33.8M (+$19.2M)

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0% more funds holding

Funds holding: 15 → 15 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
15
Holders Change
–
Holders Change %
0%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$10.5M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$4.62M
3
DM
Deerfield Management
New York
+$1.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$322K
5
PVI
Pura Vida Investments
New York
+$173K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$6.62K
2
Deutsche Bank
Deutsche Bank
Germany
-$6K
3
Jennison Associates
Jennison Associates
New York
-$3.77K
4
Goldman Sachs
Goldman Sachs
New York
-$2.39K
5
TRCT
Tower Research Capital (TRC)
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$12.1M +$4.62M +1,351,766 +64%
O
2
OrbiMed
New York
$11M +$10.5M +3,072,196 New
DM
3
Deerfield Management
New York
$6.3M +$1.4M +409,626 +30%
TP
4
Truvvo Partners
New York
$1.34M – – –
Jennison Associates
5
Jennison Associates
New York
$1.27M -$3.77K -1,102 -0.3%
TI
6
Turner Investments
Pennsylvania
$907K +$17.1K +5,000 +2%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$338K +$322K +94,251 New
PVI
8
Pura Vida Investments
New York
$285K +$173K +50,676 +176%
Renaissance Technologies
9
Renaissance Technologies
New York
$50K +$10.9K +3,200 +30%
Goldman Sachs
10
Goldman Sachs
New York
$43K -$2.39K -700 -6%
LTFS
11
Ladenburg Thalmann Financial Services
Florida
$40K – – –
UBS Group
12
UBS Group
Switzerland
$11K -$6.62K -1,937 -38%
Morgan Stanley
13
Morgan Stanley
New York
$4K – – –
TCOV
14
Trust Company of Vermont
Vermont
$4K – – –
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$3K – – –
Deutsche Bank
16
Deutsche Bank
Germany
– -$6K -2,100 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$1K -357 Closed

STDY Hedge Fund Activity: Q3 2016 in Review

15 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in SteadyMed Ltd (STDY) for Q3 2016, worth a combined $33.8M — up 131% from $14.6M a quarter earlier.

Fund positioning in STDY was balanced in Q3 2016: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 3 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $10.5M. The largest seller was UBS Group, cutting an estimated $6.62K.

  • 15 institutional investors held SteadyMed Ltd (STDY) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $33.8M of SteadyMed Ltd stock for Q3 2016, up 131% quarter-over-quarter.
  • 2 funds opened new SteadyMed Ltd positions in Q3 2016 and 2 closed out, a net change of 0 holders.
  • The largest SteadyMed Ltd buyer in Q3 2016 was OrbiMed, an estimated $10.5M added.
  • The largest SteadyMed Ltd seller in Q3 2016 was UBS Group, an estimated $6.62K sold.

Based on aggregated 13F filings for Q3 2016.